nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—ABCB1—colon cancer	0.866	1	CbGaD
Meprobamate—Proctitis—Fluorouracil—colon cancer	0.0103	0.0766	CcSEcCtD
Meprobamate—Slurred speech—Fluorouracil—colon cancer	0.00561	0.0418	CcSEcCtD
Meprobamate—Anuria—Methotrexate—colon cancer	0.00373	0.0279	CcSEcCtD
Meprobamate—Dysarthria—Irinotecan—colon cancer	0.00277	0.0207	CcSEcCtD
Meprobamate—Dysarthria—Fluorouracil—colon cancer	0.00265	0.0198	CcSEcCtD
Meprobamate—Rash maculo-papular—Fluorouracil—colon cancer	0.00228	0.017	CcSEcCtD
Meprobamate—Euphoric mood—Fluorouracil—colon cancer	0.00215	0.0161	CcSEcCtD
Meprobamate—Petechiae—Capecitabine—colon cancer	0.00213	0.0159	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Irinotecan—colon cancer	0.00201	0.015	CcSEcCtD
Meprobamate—Dermatitis bullous—Fluorouracil—colon cancer	0.0019	0.0142	CcSEcCtD
Meprobamate—Dysarthria—Capecitabine—colon cancer	0.00185	0.0138	CcSEcCtD
Meprobamate—Ataxia—Vincristine—colon cancer	0.00184	0.0137	CcSEcCtD
Meprobamate—Ataxia—Fluorouracil—colon cancer	0.00171	0.0128	CcSEcCtD
Meprobamate—Petechiae—Methotrexate—colon cancer	0.00159	0.0118	CcSEcCtD
Meprobamate—Ecchymosis—Capecitabine—colon cancer	0.00158	0.0118	CcSEcCtD
Meprobamate—Eosinophilia—Fluorouracil—colon cancer	0.00156	0.0116	CcSEcCtD
Meprobamate—Stomatitis—Vincristine—colon cancer	0.00147	0.0109	CcSEcCtD
Meprobamate—Stomatitis—Irinotecan—colon cancer	0.00143	0.0107	CcSEcCtD
Meprobamate—Vascular purpura—Capecitabine—colon cancer	0.00142	0.0106	CcSEcCtD
Meprobamate—Oliguria—Methotrexate—colon cancer	0.00142	0.0106	CcSEcCtD
Meprobamate—Dysarthria—Methotrexate—colon cancer	0.00138	0.0103	CcSEcCtD
Meprobamate—Stomatitis—Fluorouracil—colon cancer	0.00137	0.0102	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Capecitabine—colon cancer	0.00135	0.0101	CcSEcCtD
Meprobamate—Dermatitis bullous—Capecitabine—colon cancer	0.00133	0.00993	CcSEcCtD
Meprobamate—Purpura—Capecitabine—colon cancer	0.00132	0.00985	CcSEcCtD
Meprobamate—Agranulocytosis—Fluorouracil—colon cancer	0.00131	0.00977	CcSEcCtD
Meprobamate—Aplastic anaemia—Methotrexate—colon cancer	0.00122	0.00914	CcSEcCtD
Meprobamate—Ataxia—Capecitabine—colon cancer	0.0012	0.00893	CcSEcCtD
Meprobamate—Chills—Irinotecan—colon cancer	0.00118	0.0088	CcSEcCtD
Meprobamate—Ecchymosis—Methotrexate—colon cancer	0.00118	0.0088	CcSEcCtD
Meprobamate—Arrhythmia—Irinotecan—colon cancer	0.00117	0.00877	CcSEcCtD
Meprobamate—Arrhythmia—Fluorouracil—colon cancer	0.00113	0.00839	CcSEcCtD
Meprobamate—Lymphadenopathy—Methotrexate—colon cancer	0.00111	0.00828	CcSEcCtD
Meprobamate—Bronchospasm—Capecitabine—colon cancer	0.00108	0.00807	CcSEcCtD
Meprobamate—Agitation—Vincristine—colon cancer	0.00108	0.00806	CcSEcCtD
Meprobamate—Vertigo—Vincristine—colon cancer	0.00106	0.00788	CcSEcCtD
Meprobamate—Leukopenia—Vincristine—colon cancer	0.00105	0.00785	CcSEcCtD
Meprobamate—Vertigo—Irinotecan—colon cancer	0.00103	0.00767	CcSEcCtD
Meprobamate—Syncope—Irinotecan—colon cancer	0.00103	0.00766	CcSEcCtD
Meprobamate—Leukopenia—Irinotecan—colon cancer	0.00102	0.00765	CcSEcCtD
Meprobamate—Loss of consciousness—Irinotecan—colon cancer	0.00101	0.00751	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Methotrexate—colon cancer	0.001	0.00749	CcSEcCtD
Meprobamate—Leukopenia—Fluorouracil—colon cancer	0.000981	0.00732	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000972	0.00725	CcSEcCtD
Meprobamate—Anaphylactic shock—Vincristine—colon cancer	0.000959	0.00716	CcSEcCtD
Meprobamate—Stomatitis—Capecitabine—colon cancer	0.000956	0.00713	CcSEcCtD
Meprobamate—Anaphylactic shock—Irinotecan—colon cancer	0.000934	0.00697	CcSEcCtD
Meprobamate—Shock—Irinotecan—colon cancer	0.000919	0.00686	CcSEcCtD
Meprobamate—Agranulocytosis—Capecitabine—colon cancer	0.000915	0.00683	CcSEcCtD
Meprobamate—Hypotension—Vincristine—colon cancer	0.000896	0.00669	CcSEcCtD
Meprobamate—Anaphylactic shock—Fluorouracil—colon cancer	0.000895	0.00668	CcSEcCtD
Meprobamate—Ataxia—Methotrexate—colon cancer	0.000891	0.00664	CcSEcCtD
Meprobamate—Tachycardia—Fluorouracil—colon cancer	0.000873	0.00652	CcSEcCtD
Meprobamate—Hypotension—Irinotecan—colon cancer	0.000873	0.00651	CcSEcCtD
Meprobamate—Oedema peripheral—Capecitabine—colon cancer	0.000867	0.00647	CcSEcCtD
Meprobamate—Paraesthesia—Vincristine—colon cancer	0.000861	0.00643	CcSEcCtD
Meprobamate—Paraesthesia—Irinotecan—colon cancer	0.000839	0.00626	CcSEcCtD
Meprobamate—Hypotension—Fluorouracil—colon cancer	0.000836	0.00624	CcSEcCtD
Meprobamate—Erythema multiforme—Capecitabine—colon cancer	0.000832	0.00621	CcSEcCtD
Meprobamate—Somnolence—Irinotecan—colon cancer	0.000831	0.0062	CcSEcCtD
Meprobamate—Eosinophilia—Methotrexate—colon cancer	0.00081	0.00605	CcSEcCtD
Meprobamate—Paraesthesia—Fluorouracil—colon cancer	0.000804	0.00599	CcSEcCtD
Meprobamate—Somnolence—Fluorouracil—colon cancer	0.000796	0.00594	CcSEcCtD
Meprobamate—Chills—Capecitabine—colon cancer	0.00079	0.00589	CcSEcCtD
Meprobamate—Arrhythmia—Capecitabine—colon cancer	0.000786	0.00587	CcSEcCtD
Meprobamate—Body temperature increased—Vincristine—colon cancer	0.000758	0.00566	CcSEcCtD
Meprobamate—Body temperature increased—Irinotecan—colon cancer	0.000739	0.00551	CcSEcCtD
Meprobamate—Drowsiness—Methotrexate—colon cancer	0.00073	0.00545	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000724	0.0054	CcSEcCtD
Meprobamate—Stomatitis—Methotrexate—colon cancer	0.000711	0.00531	CcSEcCtD
Meprobamate—Body temperature increased—Fluorouracil—colon cancer	0.000707	0.00528	CcSEcCtD
Meprobamate—Hypersensitivity—Vincristine—colon cancer	0.000707	0.00527	CcSEcCtD
Meprobamate—Vertigo—Capecitabine—colon cancer	0.000688	0.00514	CcSEcCtD
Meprobamate—Hypersensitivity—Irinotecan—colon cancer	0.000688	0.00514	CcSEcCtD
Meprobamate—Asthenia—Vincristine—colon cancer	0.000688	0.00514	CcSEcCtD
Meprobamate—Syncope—Capecitabine—colon cancer	0.000687	0.00513	CcSEcCtD
Meprobamate—Leukopenia—Capecitabine—colon cancer	0.000686	0.00512	CcSEcCtD
Meprobamate—Agranulocytosis—Methotrexate—colon cancer	0.000681	0.00508	CcSEcCtD
Meprobamate—Palpitations—Capecitabine—colon cancer	0.000677	0.00505	CcSEcCtD
Meprobamate—Loss of consciousness—Capecitabine—colon cancer	0.000673	0.00502	CcSEcCtD
Meprobamate—Asthenia—Irinotecan—colon cancer	0.00067	0.005	CcSEcCtD
Meprobamate—Hypersensitivity—Fluorouracil—colon cancer	0.000659	0.00492	CcSEcCtD
Meprobamate—Diarrhoea—Vincristine—colon cancer	0.000656	0.0049	CcSEcCtD
Meprobamate—Diarrhoea—Irinotecan—colon cancer	0.000639	0.00477	CcSEcCtD
Meprobamate—Dizziness—Vincristine—colon cancer	0.000634	0.00473	CcSEcCtD
Meprobamate—Pruritus—Fluorouracil—colon cancer	0.000633	0.00472	CcSEcCtD
Meprobamate—Erythema multiforme—Methotrexate—colon cancer	0.000619	0.00462	CcSEcCtD
Meprobamate—Dizziness—Irinotecan—colon cancer	0.000618	0.00461	CcSEcCtD
Meprobamate—Shock—Capecitabine—colon cancer	0.000615	0.00459	CcSEcCtD
Meprobamate—Diarrhoea—Fluorouracil—colon cancer	0.000612	0.00457	CcSEcCtD
Meprobamate—Tachycardia—Capecitabine—colon cancer	0.00061	0.00455	CcSEcCtD
Meprobamate—Vomiting—Vincristine—colon cancer	0.00061	0.00455	CcSEcCtD
Meprobamate—Dermatitis—Vincristine—colon cancer	0.000604	0.00451	CcSEcCtD
Meprobamate—Headache—Vincristine—colon cancer	0.000601	0.00448	CcSEcCtD
Meprobamate—Vomiting—Irinotecan—colon cancer	0.000594	0.00443	CcSEcCtD
Meprobamate—Dizziness—Fluorouracil—colon cancer	0.000592	0.00441	CcSEcCtD
Meprobamate—Dermatitis—Irinotecan—colon cancer	0.000589	0.00439	CcSEcCtD
Meprobamate—Chills—Methotrexate—colon cancer	0.000588	0.00439	CcSEcCtD
Meprobamate—Headache—Irinotecan—colon cancer	0.000585	0.00437	CcSEcCtD
Meprobamate—Hypotension—Capecitabine—colon cancer	0.000584	0.00436	CcSEcCtD
Meprobamate—Nausea—Vincristine—colon cancer	0.00057	0.00425	CcSEcCtD
Meprobamate—Vomiting—Fluorouracil—colon cancer	0.000569	0.00424	CcSEcCtD
Meprobamate—Dermatitis—Fluorouracil—colon cancer	0.000564	0.00421	CcSEcCtD
Meprobamate—Paraesthesia—Capecitabine—colon cancer	0.000561	0.00419	CcSEcCtD
Meprobamate—Headache—Fluorouracil—colon cancer	0.000561	0.00418	CcSEcCtD
Meprobamate—Nausea—Irinotecan—colon cancer	0.000555	0.00414	CcSEcCtD
Meprobamate—Nausea—Fluorouracil—colon cancer	0.000532	0.00397	CcSEcCtD
Meprobamate—Vertigo—Methotrexate—colon cancer	0.000512	0.00382	CcSEcCtD
Meprobamate—Leukopenia—Methotrexate—colon cancer	0.000511	0.00381	CcSEcCtD
Meprobamate—Body temperature increased—Capecitabine—colon cancer	0.000494	0.00369	CcSEcCtD
Meprobamate—Anaphylactic shock—Methotrexate—colon cancer	0.000465	0.00347	CcSEcCtD
Meprobamate—Hypersensitivity—Capecitabine—colon cancer	0.000461	0.00344	CcSEcCtD
Meprobamate—Asthenia—Capecitabine—colon cancer	0.000449	0.00335	CcSEcCtD
Meprobamate—Pruritus—Capecitabine—colon cancer	0.000442	0.0033	CcSEcCtD
Meprobamate—Hypotension—Methotrexate—colon cancer	0.000435	0.00325	CcSEcCtD
Meprobamate—Diarrhoea—Capecitabine—colon cancer	0.000428	0.00319	CcSEcCtD
Meprobamate—Paraesthesia—Methotrexate—colon cancer	0.000418	0.00312	CcSEcCtD
Meprobamate—Somnolence—Methotrexate—colon cancer	0.000414	0.00309	CcSEcCtD
Meprobamate—Dizziness—Capecitabine—colon cancer	0.000414	0.00309	CcSEcCtD
Meprobamate—Vomiting—Capecitabine—colon cancer	0.000398	0.00297	CcSEcCtD
Meprobamate—Dermatitis—Capecitabine—colon cancer	0.000394	0.00294	CcSEcCtD
Meprobamate—Headache—Capecitabine—colon cancer	0.000392	0.00292	CcSEcCtD
Meprobamate—Nausea—Capecitabine—colon cancer	0.000371	0.00277	CcSEcCtD
Meprobamate—Body temperature increased—Methotrexate—colon cancer	0.000368	0.00275	CcSEcCtD
Meprobamate—Hypersensitivity—Methotrexate—colon cancer	0.000343	0.00256	CcSEcCtD
Meprobamate—Asthenia—Methotrexate—colon cancer	0.000334	0.00249	CcSEcCtD
Meprobamate—Pruritus—Methotrexate—colon cancer	0.000329	0.00246	CcSEcCtD
Meprobamate—Diarrhoea—Methotrexate—colon cancer	0.000318	0.00238	CcSEcCtD
Meprobamate—Dizziness—Methotrexate—colon cancer	0.000308	0.0023	CcSEcCtD
Meprobamate—Vomiting—Methotrexate—colon cancer	0.000296	0.00221	CcSEcCtD
Meprobamate—Dermatitis—Methotrexate—colon cancer	0.000293	0.00219	CcSEcCtD
Meprobamate—Headache—Methotrexate—colon cancer	0.000292	0.00218	CcSEcCtD
Meprobamate—Nausea—Methotrexate—colon cancer	0.000276	0.00206	CcSEcCtD
